Company eyeing growth prospects in the region amidst international tie-ups
NOT many in the pharmaceutical industry are looking at biosimilar medicine, but it is an area that Inno Bio Ventures Sdn Bhd (IBV) chairman Tan Sri Abdul Rahman Mamat intends to build the company on.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
